The convergence of new technologies and therapies is reshaping the entire landscape of healthcare. Panelists share their perspectives on how therapeutic applications, clinical trials, drug delivery, and adherence will be altered by digital medicine’s influence.
Moderator: Nima Jokilaakso – Swecare
- Alexandra Eberhard – Signal Analytics
- Tracy Mayne – Purdue Pharma L.P.
- Peter Neubeck – ExB Labs
- Matthew Owens – Novartis